A macrolide compound represented by the formula (I) effective against erythromycin resistant bacteria (for example, resistant pneumococci, streptococci and mycoplasmas).
申请人:HELMHOLTZ-ZENTRUM FÜR INFEKTIONSFORSCHUNG GMBH
公开号:US11034648B2
公开(公告)日:2021-06-15
The present invention relates to novel derivatives of cystobactamides of formula (Ib) and the use thereof for the treatment or prophylaxis of bacterial infections.
本发明涉及式(Ib)胱内酰胺的新型衍生物及其在治疗或预防细菌感染中的应用。
NOVEL CYSTOBACTAMIDE DERIVATIVES
申请人:HELMHOLTZ-ZENTRUM FÜR INFEKTIONSFORSCHUNG GMBH
公开号:US20200190020A1
公开(公告)日:2020-06-18
The present invention relates to novel derivatives of cystobactamides of formula (Ib) and the use thereof for the treatment or prophylaxis of bacterial infections.
US9139609B2
申请人:——
公开号:US9139609B2
公开(公告)日:2015-09-22
Chemoselective Cleavage of Acylsulfonamides and Sulfonamides by Aluminum Halides
The chemoselective cleavage of C–N bonds of amides, sulfonamides, and acylsulfonamides by aluminum halides is described. AlCl3 and AlI3 display complementary reactivities toward N-alkyl and N-acyl moieties. N-Alkylacylsulfonamides, secondary N-(tert-butyl)sulfonamides, and tertiary N-(tert-butyl)amides undergo N-dealkylation upon treatments with AlI3 generated in situ from aluminum and iodine in acetonitrile